These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6186369)

  • 41. Extracellular recovery of methotrexate-polyglutamates following efflux from L1210 leukemia cells.
    Poser RG; Sirotnak F; Chello PL
    Biochem Pharmacol; 1980 Oct; 29(19):2701-4. PubMed ID: 6158955
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacokinetics of the poly-gamma-glutamyl metabolites of methotrexate in skin and other tissues of rats and hairless mice.
    Zimmerman CL; Franz TJ; Slattery JT
    J Pharmacol Exp Ther; 1984 Nov; 231(2):242-7. PubMed ID: 6208357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose transport in developing Ehrlich ascites tumor cells: parallel changes in the rate of glucose uptake and cytochalasin B binding activity during tumor development and methotrexate treatment.
    Chan TW; Fung KP; Choy YM; Lee CY
    Arch Biochem Biophys; 1983 Sep; 225(2):458-66. PubMed ID: 6625594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate: an effective agent for treating cancer and building careers. The polyglutamate era.
    Schilsky RL
    Stem Cells; 1996 Jan; 14(1):29-32. PubMed ID: 8820948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. K+ transport and glycolysis.
    Gordon EE
    Diabetes; 1968; 17():301-2. PubMed ID: 5689960
    [No Abstract]   [Full Text] [Related]  

  • 46. The kinetics of methotrexate polyglutamate formation and efflux in a human breast cancer cell line (MDA.MB.436): the effect of insulin.
    Kennedy DG; Clarke R; van den Berg HW; Murphy RF
    Biochem Pharmacol; 1983 Jan; 32(1):41-6. PubMed ID: 6187348
    [No Abstract]   [Full Text] [Related]  

  • 47. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
    Zhao R; Babani S; Gao F; Liu L; Goldman ID
    Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for the cytotoxic activity of polyglutamate derivatives of methotrexate.
    Galivan J
    Mol Pharmacol; 1980 Jan; 17(1):105-10. PubMed ID: 6155601
    [No Abstract]   [Full Text] [Related]  

  • 49. Alterations of the carrier-mediated transport of an anionic solute, methotrexate, by charged liposomes in Ehrlich ascites tumor cells.
    Fry DW; White JC; Goldman ID
    J Membr Biol; 1979 Oct; 50(2):123-40. PubMed ID: 501733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lack of stereospecificity at carbon 6 of methyltetrahydrofolate transport in Ehrlich ascites tumor cells. Carrier-mediated transport of both stereoisomers.
    White JC; Bailey BD; Goldman ID
    J Biol Chem; 1978 Jan; 253(1):242-5. PubMed ID: 618860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
    Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Active transport of glucose anomers by ascites tumour cells.
    Fishman PH; Bailey JM
    Nat New Biol; 1973 May; 243(123):59-60. PubMed ID: 17315372
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of D,L-4-fluoroglutamic acid on glutamylation of methotrexate by hepatic cells in vitro.
    Galivan J; Coward JK; McGuire JJ
    Biochem Pharmacol; 1985 Aug; 34(16):2995-7. PubMed ID: 2411272
    [No Abstract]   [Full Text] [Related]  

  • 55. Evidence for negative feedback of extracellular methotrexate on blasts of acute lymphoblastic leukemia in vitro.
    Hum MC; Smith AK; Lark RH; Winick NJ; Kamen BA
    Pharmacotherapy; 1997; 17(6):1260-6. PubMed ID: 9399609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved methotrexate therapy of murine tumors obtained by probenecid-mediated pharmacological modulation at the level of membrane transport.
    Sirotnak FM; Moccio DM; Hancock CH; Young CW
    Cancer Res; 1981 Oct; 41(10):3944-9. PubMed ID: 7285003
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro formation of polyglutamyl derivatives of methotrexate and 7-hydroxymethotrexate in human lymphoblastic leukemia cells.
    Fabre G; Matherly LH; Favre R; Catalin J; Cano JP
    Cancer Res; 1983 Oct; 43(10):4648-52. PubMed ID: 6192907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of levorin on the activity of facilitated diffusion systems in murine Ehrlich cancer cells].
    Lishnevskaia EB; Gorozhankina IS; Tereshin IM
    Antibiotiki; 1982 Feb; 27(2):141-4. PubMed ID: 7065649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the inhibitory effects of VP-16-213 (etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrlich ascites tumor cells in vitro.
    Yalowich JC; Goldman ID
    Cancer Res; 1984 Mar; 44(3):984-9. PubMed ID: 6692420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumor.
    Skovsgaard T
    Cancer Res; 1980 Apr; 40(4):1077-83. PubMed ID: 7357538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.